scarlet fever antitoxin (equine)

Animal productapproved

Approved

Jul 1, 1925

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1920s

  1. Jul 1, 1925

    Earliest FDA Approval

Indications

Mechanism of action

Approval history

  • approvedJul 1, 1925

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • scarlet fever antitoxin (equine)